• Home
  • News
  • Portfolio News
  • Astrocyte Pharmaceuticals Awarded Major Grant to Further Develop Promising Treatment for Brain Injury

Astrocyte Pharmaceuticals Awarded Major Grant to Further Develop Promising Treatment for Brain Injury

08Sep

Astrocyte Pharmaceuticals Awarded Major Grant to Further Develop Promising Treatment for Brain Injury

Portfolio News

Astrocyte Pharmaceuticals Inc., a drug discovery and development company advancing novel neuroprotective therapeutics for the treatment of brain injuries, announced today that it has received a $500,000 award jointly funded by the Medical Technology Enterprise Consortium (MTEC) and the BrightFocus Foundation. Read more >>

Share this post

Related Posts

27Feb

Aras Announces Audi, BMW, L3, Microsoft, and Schaeffler to Headline ACE 2018 Global Conference on Digital Transformation

Aras, the leader in open, enterprise product lifecycle management (PLM) software, today announced that speakers from Audi, BMW, L3, Microsoft,... read more
20May

PNC Bank Expands Financial Wellness Offerings With PNC Student Debt Solution, Powered by Candidly™

PNC Bank, N.A. today announced an expansion of its financial wellness offerings for clients through the introduction of PNC Student... read more
23May

Fishmeal substitute passes taste test

Sashimi derived from yellowtail fed a diet containing a novel fishmeal replacement has passed a consumer taste test with flying... read more
27Mar

You Can Now Rent Toys Netflix-Style And We Approve

“It’s the way many millennial parents shop now. We want to access the expensive products without having to spend a... read more
04Jun

Zylö Therapeutics Closes $5.225 Million Series B Financing

Zylö Therapeutics Inc., dedicated to developing a transformational drug-delivery platform, announced that it has raised $5.225 million in its Series... read more
20Oct

MIN 134 Women Founders 2020

WEBOS Week 2020 is a curated week of programming and events hosted by partners throughout the City of Boston, focused... read more
10Dec

Pittsburgh-based company behind ‘promising’ new COVID-19 treatment

On Wednesday, the Wolf Administration plans to highlight what it calls in a news advisory a “promising new drug candidate... read more
09Aug

City Council Approves Purchase of Mass Notification System

The city of Kirksville, Mo., will soon be using a new mass notification system to warn local residents about emergencies... read more
31Dec

Corbus Concludes Phase II study of Cystic Fibrosis Candidate

Corbus Pharmaceuticals Holdings, Inc. CRBP , recently announced that it has concluded Phase II trial evaluating pipeline candidate, JBT-101 (resunab),... read more
25Aug

NextShift Robotics, An Autonomous Mobile Robot Company Worth Following

Headquartered in Lowell, MA in the US, this 2016 startup provides second generation AMRs that have mechanical gripper arms. They... read more